Skip to main content
I am a ...
Patient or Caregiver
Overview
Diseases We Study
Real Stories
Clinical Trials
Support and Resources
Healthcare Professional
Overview
Medical Information
Clinical Data Requests
Investigator-Sponsored Trials
Medical Education Grants
I am a ...
Patient or Caregiver
Healthcare Professional
Who We Are
Mission and Values
Our History
Corporate Responsibility
Diversity, Equity, and Inclusion
Leadership
Citizenship
Partnerships
Ethics and Compliance
Our Science
Technologies
Pipeline
Brentuximab Vedotin
Enfortumab Vedotin
Ladiratuzumab Vedotin
Tisotumab Vedotin
Tucatinib
Clinical Trials
Access to Investigational Therapies
Our Medicines
ADCETRIS®
(brentuximab vedotin)
PADCEV®
(enfortumab vedotin-ejfv)
TIVDAK®
(tisotumab vedotin-tftv)
TUKYSA®
(tucatinib)
Featured Content
Seagen25
Join Us
Benefits
Culture
Explore Jobs
News
Investors
Search
Cancel
Cancel Search
Quarterly results
Investor Menu
Overview
Press releases
Events and presentations
Stock information
Stock quote and chart
Analyst coverage
Financial information
Quarterly results
SEC filings
Annual reports and proxy
Corporate governance
Corporate governance
Executive management
Board of directors
Committee composition
Resources
Frequently asked questions
Information request
Email alerts
Financial summary